Keyphrases
Tumor Necrosis Factor-α
87%
Tumor
60%
Chemotherapy
54%
Successful Treatment
46%
Multiple Myeloma
44%
Chronic Myeloid Leukemia
43%
Induced Apoptosis
36%
Older Men
34%
Leukemic Cells
34%
5-fluorouracil (5-FU)
33%
Myelodysplastic Syndrome
32%
Cytotoxicity
31%
Phase II Study
31%
Apoptosis
30%
Older Women
29%
Docetaxel
29%
Adenovirus
29%
Neutropenia
28%
Hepatocellular Carcinoma
28%
Malignant Lymphoma
28%
Graft-versus-host Disease (GvHD)
28%
Adriamycin
27%
TNF Receptor 1 (TNFR1)
26%
Acute Myeloid Leukemia
26%
Bone Marrow
26%
Tumor Cells
25%
Liposomes
24%
Diffuse Large B-cell Lymphoma (DLBCL)
24%
Esophageal Cancer
23%
Granulocyte Colony-stimulating Factor (G-CSF)
22%
Rituximab
22%
Combination Chemotherapy
21%
Resistance Factor
21%
T Cells
20%
Binding Activity
20%
Myelofibrosis
20%
Hepatitis B Virus
20%
Complete Response
20%
Liver
20%
Transforming Growth Factor-β
20%
Lymphoma Cells
19%
Fucose
19%
Phase II Trial
19%
Complete Remission
19%
Stromal Cells
19%
Hematopoietic Stem Cells
19%
Prednisolone
19%
Young Males
19%
Reactive Oxygen Species
19%
Cyclosporine
18%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
100%
Chemotherapy
76%
Neoplasm
59%
Doxorubicin
41%
Cytotoxicity
35%
Remission
32%
Multiple Myeloma
31%
Chronic Myeloid Leukemia
29%
Docetaxel
29%
Abdominal Cancer
29%
Acute Myeloid Leukemia
28%
Myelodysplastic Syndrome
26%
Neutropenia
24%
Tumor Necrosis Factor Receptor
24%
Pancreas Carcinoma
23%
Anticarcinogen
22%
Fluorouracil
20%
R-Factor
20%
Liposome
20%
Disease
19%
Adverse Event
19%
Superoxide Dismutase
18%
Liver Cell Carcinoma
17%
Esophagus Cancer
17%
Metastatic Colorectal Cancer
17%
Heat Shock Transcription Factor 1
17%
Digestive System Cancer
17%
Deferasirox
17%
Gene Delivery
17%
Chemoradiation Therapy
17%
Leukemia
16%
Small Interfering RNA
16%
Cyclophosphamide
16%
Reactive Oxygen Metabolite
15%
Cisplatin
15%
Retrospective Study
14%
Hepatitis B Virus
14%
Drug Resistance
14%
Nonalcoholic Fatty Liver
14%
Imatinib
14%
Pancreas Cancer
13%
Chaperone
13%
Malignant Neoplasm
13%
Heat Shock Protein 47
13%
Overall Survival
12%
Denosumab
12%
Receptor
12%
Oxaliplatin
12%
Lymphoma
12%
Cytarabine
12%
Medicine and Dentistry
Neoplasm
90%
Chemotherapy
76%
Acute Myeloid Leukemia
40%
Multiple Myeloma
31%
Chronic Myelogenous Leukemia
30%
Myelodysplastic Syndrome
30%
Lymphoma Cell
28%
Hepatocellular Carcinoma
27%
Lymphoma
27%
Metastatic Carcinoma
26%
T Cell
24%
Graft Versus Host Reaction
23%
Adenoviridae
23%
Abdominal Cancer
23%
Diffuse Large B-Cell Lymphoma
23%
Disease
22%
T-Cell Lymphoma
21%
Hepatitis B Virus
20%
Cyclosporine
19%
Retrospective Study
19%
Hematopoietic Cell
18%
Tumor Necrosis Factor
18%
Hemophagocytic Syndrome
17%
Chemoradiotherapy
17%
Acute Graft Versus Host Disease
17%
Rituximab
16%
Leukemia
16%
Liver Metastasis
16%
Cancer Cell
16%
Granulocyte Colony Stimulating Factor
15%
Carcinoma
15%
Liposome
15%
Promoter Region
14%
Hematopoietic Stem Cell Transplantation
14%
Minimal Residual Disease
14%
Drug Resistance
14%
Leukemia Cell
13%
Colon
13%
Prednisolone
13%
Programmed Cell Death
13%
Endoscopic Ultrasound
13%
Combination Chemotherapy
13%
Myelofibrosis
13%
Diagnosis
13%
Arm
13%
Anemia
13%
Stromal Cell
13%
Cytarabine
13%
Lung Metastasis
12%
Peripheral T-Cell Lymphoma
12%